[1] IOLASCON G, DE SIRE A, CURCI C, et al. Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II. Eur J Phys Rehabil Med. 2021;57(2):273-279.
[2] ZOU Z, LIU W, CAO L, et al. Advances in the occurrence and biotherapy of osteoporosis. Biochem Soc Trans. 2020;48(4):1623-1636.
[3] NOH JY, YANG Y, JUNG H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 2020;21(20):7623.
[4] SHEN Y, HUANG X, WU J, et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Front Endocrinol (Lausanne). 2022;13:882241.
[5] 中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂,2019,12(4):317-318.
[6] 朱洁云,高敏,宋秋韵,等.中国老年人骨质疏松症患病率的Meta分析[J].中国全科医学,2022,25(3):346-353.
[7] 文学,孙红,王洪,等.PTHrP类似物阿巴洛肽在骨质疏松症中的研究进展[J].中华老年骨科与康复电子杂志,2021,7(2):117-121.
[8] ZHUO Y, LI M, JIANG Q, et al. Evolving roles of natural terpenoids from traditional chinese medicine in the treatment of osteoporosis. Front Endocrinol (Lausanne). 2022;13:901545.
[9] CAPECE D, VERZELLA D, FLATI I, et al. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757-775.
[10] SEN R, BALTIMORE D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705-716.
[11] FRANZOSO G, CARLSON L, XING L, et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997;11(24):3482-3496.
[12] ALI NN, GILSTON V, WINYARD PG. Activation of NF-kappaB in human osteoblasts by stimulators of bone resorption. FEBS Lett. 1999;460(2):315-320.
[13] KASAMA T, ISOZAKI T, ODAI T, et al. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma. Transl Res. 2007;149(5):265-273.
[14] ZHEN R, YANG J, WANG Y, et al. Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein2mediated NFκB signaling pathway. Mol Med Rep. 2018;17(4):6045-6053.
[15] PENG Y, LV S, LI Y, et al. Glucocorticoids disrupt skeletal angiogenesis through transrepression of NF-κB-mediated preosteoclast Pdgfb transcription in young mice. J Bone Miner Res. 2020;35(6):1188-1202.
[16] POMA P. NF-κB and Disease. Int J Mol Sci. 2020;21(23):9181.
[17] YU H, LIN L, ZHANG Z, et al. Targeting NF-κB pathway for the therapy of diseases:mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209.
[18] THOMS HC, STARK LA. The NF-κB nucleolar stress response pathway. Biomedicines. 2021;9(9):1082.
[19] MULERO MC, HUXFORD T, GHOSH G. NF-κB, IκB, and IKK: integral components of immune system signaling. Adv Exp Med Biol. 2019;1172:207-226.
[20] LU RJ, XING HL, LIU CJ, et al. Antibacterial peptides inhibit MC3T3-E1 cells apoptosis induced by TNF-αthrough p38 MAPK pathway. Ann Transl Med. 2020;8(15):943.
[21] REMMERS SJA, YAN DER HEIJDEN FC, DE WILDT BWM, et al. Tuning the resorption-formation balance in an in vitro 3D osteoblast-osteoclast co-culture model of bone. Bone Rep. 2022;18:101646.
[22] MISHRA R, SEHRING I, CEDERLUND M, et al. NF-κB signaling negatively regulates osteoblast dedifferentiation during zebrafish bone regeneration. Dev Cell. 2020;52(2):167-182.
[23] HE YQ, YANG H, SHEN Y, et al. Monotropein attenuates ovariectomy and LPS-induced bone loss in mice and decreases inflammatory impairment on osteoblast through blocking activation of NF-κB pathway. Chem Biol Interact. 2018;291:128-136.
[24] LIANG X, LI B, HUANG Q, et al. Klotho prevents DEX-induced apoptosis in MC3T3-E1 osteoblasts through the NF-κB signaling pathway. Biochem Biophys Res Commun. 2018;507(1-4):355-361.
[25] QUYANG X, LI S, DING Y. et al. Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway. J Musculoskelet Neuronal Interact. 2022;22(2):242-250.
[26] TIAN H, CHEN F, WANG Y, et al. Nur77 prevents osteoporosis by inhibiting the nf-κb signalling pathway and osteoclast differentiation. J Cell Mol Med. 2022;26(8):2163-2176.
[27] ZHUANG Q, CHEN S, ZHANG W, et al. Avicularin alleviates osteoporosis in ovariectomized mice by inhibiting osteoclastogenesis through NF-κB pathway inhibition. J Agric Food Chem. 2022. doi: 1021.2/acs.jafc.05954.
[28] KIM B, LEE KW, PARK B. Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-κB/ERK signaling pathway in Raw264. 7 cells. Phytomedicine. 2018;51:181-190.
[29] SWARNKAR G, CHEN TH, ARRA M, et al. NUMBL interacts with TAK1, TRAF6 and NEMO to negatively regulate NF-κB signaling during osteoclastogenesis. Sci Rep. 2017;7(1):12600.
[30] XU J, WU HF, ANG ES, et al. NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev. 2009;20(1):7-17.
[31] DONG M, ZENG J, YANG C, et al. Asiatic acid attenuates osteoporotic bone loss in ovariectomized mice through inhibiting NF-kappaB/MAPK/Protein Kinase B signaling pathway. Front Pharmacol. 2022;13:829741.
[32] ZHANG F, HUANG X, QI Y, et al. Juglanin inhibits osteoclastogenesis in ovariectomized mice via the suppression of NF-κB signaling pathways. Front Pharmacol. 2021;11:596230.
[33] SHEN G, LIUI X, LEI W, et al. Plumbagin is a NF-κB-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice. J Biol Chem. 2022;298(4):101767.
[34] AVNET S, CHANO T, MASSA A, et al. Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway. Am J Cancer Res. 2019;9(6):1127-1144.
[35] YAO Z, LEI W, DUAN R, et al. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors. J Biol Chem. 2017;292(24):10169-10179.
[36] WANG W, WANG B. Expression of angiogenesis-related proteins in bone marrow mesenchymal stem cells induced by osteoprotegerin during osteogenic differentiation in rats. Int Immunopharmacol. 2021;98:107821.
[37] FAN D, LU J, YU N, et al. Curcumin prevents diabetic osteoporosis through promoting osteogenesis and angiogenesis coupling via NF-κB signaling. Evid Based Complement Alternat Med. 2022;2022:4974343.
[38] LIN X, XU F, ZHANG KW, et al. Acacetin prevents bone loss by disrupting osteoclast formation and promoting type H vessel formation in ovariectomy-induced osteoporosis. Front Cell Dev Biol. 2022;10:796227.
[39] 张杰,董万涛,赵宝宝,等.中医药干预骨质疏松成血管-成骨耦联因子研究进展[J].中国骨质疏松杂,2023,29(1):151-156.
[40] KANWAL A, BILAL M, RASOOL N, et al. Total synthesis of terpenes and their biological significance: a critical review. Pharmaceuticals (Basel). 2022;15(11):1392.
[41] NINKUU V, ZHANG L, YANG J, et al. Biochemistry of terpenes and recent advances in plant protection. Int J Mol Sci. 2021;22(11):5710.
[42] BELLAVIA D, CARADONNA F, DIMARCO E, et al. Terpenoid treatment in osteoporosis: this is where we have come in research. Trends Endocrinol Metab. 2021;32(11):846-861.
[43] GAO Y, WANG T, WANNG G, et al. Preclinical safety of ginsenoside compound K: acute, and 26-week oral toxicity studies in mice and rats. Food Chem Toxicol. 2019;131: 110578.
[44] NURCAHYANTI ADR, SATRIAWAN N, SHAROPOV F. Free radical scavenging synergism of fucoxanthin with lipophilic plant products. Nat Prod Res. 2023;37(5):782-787.
[45] ZOU L, DING W, HUANG Q, et al. Andrographolide/phospholipid/cyclodextrin complex-loaded nanoemulsion: preparation, optimization, in vitro and in vivo evaluation. Biol Pharm Bull. 2022;45(8):1106-1115.
[46] WANG Y,DAI J, ZHU Y, et al. Paeoniflorin regulates osteoclastogenesis and osteoblastogenesis via manipulating NF-κB signaling pathway both in vitro and in vivo. Oncotarget. 2017;9(7):7372-7388.
[47] JIN M, FENG H, WANG Y, et al. Gentiopicroside ameliorates oxidative stress and lipid accumulation through nuclear factor erythroid 2-related factor 2 activation. Oxid Med Cell Longev. 2020;2020:2940746.
[48] CHEN F, XIE L, KANG R, et al. Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways. Biomed Pharmacother. 2018;100: 142-146.
[49] CHAWALITPONG S, CHOKCHAISIRI R, SUKSAMRAM A, et al. Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway. Sci Rep. 2018;8(1):5625.
[50] 徐硕,姜文清,吴学军,等.中药中二萜类化学成分分析方法的研究进展[J].西北药学杂志,2020,35(5):788-791.
[51] ZHU M, SHAN J, XU H, et al. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways. J Ethnopharmacol. 2021;276:114176.
[52] ZHU S, WEI W, LIU Z, et al. Tanshinone IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NFκB signaling pathway. Mol Med Rep. 2018;17(5):6969-6976.
[53] WANG W, HUANG M, HUI Y, et al. Cryptotanshinone inhibits RANKL-induced osteoclastogenesis by regulating ERK and NF-κB signaling pathways. J Cell Biochem. 2019;120(5):7333-7340.
[54] 丁丁,车千红,徐樱溪,等.穿心莲内酯通过抑制TNF-α活化的核转录因子κB信号途径保护和促进成骨分化[J].解剖科学进展,2019,25(3):316-319,334.
[55] 李婧,程梁,郭吕华,等.银杏叶中异鼠李素对RAW264.7细胞向破骨细胞分化的影响及其分子机制[J].口腔疾病防治,2018,26(3):158-165.
[56] LIU SP, WANG GD, DU XJ, et al. Triptolide inhibits the function of TNF-αin osteoblast differentiation by inhibiting the NF-κB signaling pathway. Exp Ther Med. 2017;14(3): 2235-2240.
[57] XIE Z, YU H, SUN X, et al. A novel diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting ifrd1-mediated and IκBα-mediated p65 nuclear translocation. J Bone Miner Res. 2018;33(4):667-678.
[58] MA X, LIU Y, ZHANG Y, et al. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways. Biochem Biophys Res Commun. 2014;445(2):282-288.
[59] BAI Q, WANG X, MAO X, et al. Aldo-keto reductase 1 member B1(AKR1B1)inhibits retinal ganglion cell activity via activating NF-κB pathway and inducing mouse BV-2 microglia activation. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36(12):1063-1068.
[60] 陈莎,周佳瑛,储非凡,等.甜菊素对RANKL诱导的破骨细胞分化和功能的影响[J].中成药,2022,44(6):1804-1809.
[61] LIU S, LIU H, ZHANG L, et al. Edible pentacyclic triterpenes: a review of their sources, bioactivities, bioavailability, self-assembly behavior, and emerging applications as functional delivery vehicles. Crit Rev Food Sci Nutr. 2022. doi: 1080.10408398/2022.2153238.36476115.
[62] LI X, LIN X, WU Z, et al. Pristimerin protects against OVX-mediated bone loss by attenuating osteoclast formation and activity via inhibition of RANKL-mediated activation of NF-κB and ERK signaling pathways. Drug Des Devel Ther. 2021;15:61-74.
[63] PARK GD, CHEON YH, EUN SY, et al. β-boswellic acid inhibits RANKL-induced osteoclast differentiation and function by attenuating NF-κB and Btk-PLCγ2 signaling pathways. Molecules. 2021;26(9):2665.
[64] TANG Y, LV XL, BAO YZ, et al. Glycyrrhizin improves bone metabolism inovariectomized mice via inactivating NF-κB signaling. Climacteric. 2021;24(3):253-260.
[65] HSIAO HB, WU JB, LIN WC. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc1 signaling pathways. BMC Complement Altern Med. 2017;17(1):245.
[66] JIANG C, XIAO F, GU X, et al. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling. Biochimie. 2015;111:107-18.
[67] YANG JH, LI B, WU Q, et al. Echinocystic acid inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and ERK signaling pathways. Biochem Biophys Res Commun. 2016; 477(4):673-677.
[68] 柳嘉伟,苏柯,黄鑫,等.人参皂苷Rb2体内抑制破骨细胞的作用及其机制研究[J].中国骨与关节杂志,2020,9(4):293-298.
[69] ZHAO XL, CHEN LF, WANG Z. Aesculin modulates bone metabolism by suppressing receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis and transduction signals. Biochem Biophys Res Commun. 2017;488(1):15-21.
[70] YANG S, LI X, CHENG L, et al. Tenuigenin inhibits RANKL-induced osteoclastogenesis by down-regulating NF-κB activation and suppresses bone loss in vivo. Biochem Biophys Res Commun. 2015;466(4):615-621.
[71] ZHOU C, LIU W, HE W, et al. Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-κB and MAPK pathways. Int Immunopharmacol. 2015;25(1):49-54.
[72] HAN J, GAO W, SU D, et al. Gypenoside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB, AKT, and MAPK signaling pathways. J Cell Biochem. 2018;119(9):7310-7318.
[73] MAOKA T. Carotenoids as natural functional pigments. J Nat Med. 2020;74:1-16.
[74] GAO SS, ZHAO Y. The effects ofβ-carotene on osteoporosis:a systematic review and meta-analysis of observational studies. Osteoporos Int. 2022. doi: 1007.00198/s022-06593-7-36380163.
[75] WANG F, WANG N, GAO Y, et al. β-Carotene suppresses osteoclastogenesis and bone resorption by suppressing NF-κB signaling pathway. Life Sci. 2017;174:15-20. |